Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

The hidden scale-out problem behind CAR-T’s growth

CAR-T’s commercial challenge is making thousands of patient-specific manufacturing runs behave like one reliable system. "In vivo" production techniques could be one solution.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Thursday 3 September →